$17.30
1.94% yesterday
Nasdaq, Dec 02, 10:00 pm CET
ISIN
US10501L1061
Symbol
BWAY

Brainsway Ltd Sponsored ADR Stock price

$17.30
-0.08 0.46% 1M
+7.08 69.28% 6M
+7.87 83.46% YTD
+7.39 74.57% 1Y
+15.48 850.55% 3Y
+10.84 167.80% 5Y
+6.30 57.27% 10Y
+6.30 57.27% 20Y
Nasdaq, Closing price Tue, Dec 02 2025
+0.33 1.94%

Key metrics

Basic
Market capitalization
$342.5m
Enterprise Value
$270.7m
Net debt
positive
Cash
$78.0m
Shares outstanding
37.8m
Valuation (TTM | estimate)
P/E
133.1 | 36.8
P/S
7.4 | 1.9
EV/Sales
5.9 | 1.5
EV/FCF
14.5
P/B
5.0
Financial Health
Equity Ratio
66.1%
Return on Equity
4.7%
ROCE
2.2%
ROIC
19.1%
Debt/Equity
0.1
Financials (TTM | estimate)
Revenue
$46.1m | $178.7m
EBITDA
$3.8m | $6.3m
EBIT
$1.9m | $9.2m
Net Income
$5.3m | $17.8m
Free Cash Flow
$18.7m
Growth (TTM | estimate)
Revenue
26.5% | 335.6%
EBITDA
88.1% | 215.2%
EBIT
155.3% | 564.3%
Net Income
775.4% | 508.6%
Free Cash Flow
220.7%
Margin (TTM | estimate)
Gross
74.5%
EBITDA
8.2% | 3.5%
EBIT
4.1%
Net
11.6% | 9.9%
Free Cash Flow
40.6%
More
EPS
$0.1
FCF per Share
$0.5
Short interest
0.4%
Employees
-
Rev per Employee
-
Show more

Is Brainsway Ltd Sponsored ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,078 stocks worldwide.

Brainsway Ltd Sponsored ADR Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Brainsway Ltd Sponsored ADR forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a Brainsway Ltd Sponsored ADR forecast:

Buy
86%
Hold
14%

Financial data from Brainsway Ltd Sponsored ADR

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
46 46
26% 26%
100%
- Direct Costs 12 12
28% 28%
25%
34 34
26% 26%
75%
- Selling and Administrative Expenses 24 24
19% 19%
52%
- Research and Development Expense 8.53 8.53
35% 35%
19%
3.80 3.80
88% 88%
8%
- Depreciation and Amortization 1.93 1.93
50% 50%
4%
EBIT (Operating Income) EBIT 1.87 1.87
155% 155%
4%
Net Profit 5.34 5.34
775% 775%
12%

In millions USD.

Don't miss a Thing! We will send you all news about Brainsway Ltd Sponsored ADR directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Brainsway Ltd Sponsored ADR Stock News

Neutral
Seeking Alpha
one day ago
BrainsWay Ltd. (BWAY) Analyst/Investor Day Transcript
Neutral
GlobeNewsWire
8 days ago
BURLINGTON, Mass. and JERUSALEM, Nov. 25, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation technologies, today announced that it will host a virtual Analyst & Investor Day on Monday, December 1, 2025 at 10:00 AM ET, during which company management will highlight various aspects of BrainsWay's ...
Neutral
GlobeNewsWire
16 days ago
Multicenter, randomized, controlled study will evaluate Company's next-generation multichannel TMS technology in reducing heavy drinking and cravings Multicenter, randomized, controlled study will evaluate Company's next-generation multichannel TMS technology in reducing heavy drinking and cravings
More Brainsway Ltd Sponsored ADR News

Company Profile

Brainsway Ltd. is a commercial stage medical device company, which focuses on the development and sale of non-invasive neuromodulation products using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The Deep TMS uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. The company was founded by Avner Hagai, Yiftach Roth, Abraham Zangen, and David Zacut on November 7, 2006 and is headquartered in Jerusalem, Israel.

Head office Israel
CEO Mr. Levy
Founded 2006
Website www.brainsway.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today